Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Nurix Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 196
- +17 vs. Q4 2025
- Shares held
- 117.0M
- +9.58M (+8.9%) vs. Q4 2025
- Total value
- $1.81B
- −$224.5M (−11.0%) vs. Q4 2025
- New holders
- 44
- 67 more added
- Sold out
- 27
- 43 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −124,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −118,481−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −77,775−100.0% | Sold out |
| Tema ETFs LLC | 0 | $0 | 0.00% | −76,625−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −74,869−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −68,754−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −36,820−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −34,760−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −20,137−100.0% | Sold out |
| Seven Fleet Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −11,150−100.0% | Sold out |
| Opal Capital LLC | 0 | $0 | 0.00% | −12,078−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −10,172−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,175−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −3,149−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −2,820−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −338−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |